Form D — ProPhase Labs, Inc.
0001641172-25-022239 · filed Aug 5, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $6,000,000
- Reported amount sold
- $3,000,000
- Minimum investment
- $500,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ProPhase Labs, Inc.
- CIK
- 868278
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 626 RXR PLAZA, 6TH FLOOR
UNIONDALE, New York 11556 - Phone
- 215-345-0919
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
TED KARKUS · Executive OfficerUNIONDALE, New York Find on LinkedIn ↗
-
LOUIS GECKEL · DirectorUNIONDALE, New York Find on LinkedIn ↗
-
WARREN HIRSCH · DirectorUNIONDALE, New York Find on LinkedIn ↗
-
CAROLINA ABENANTE · DirectorUNIONDALE, New York Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗